Literature DB >> 16678920

Protection of Balb/c mice against infection with FMDV by immunostimulation with CpG oligonucleotides.

Søren Kamstrup1, Tine Holland Frimann, Annette Malene Barfoed.   

Abstract

Oligodeoxynucleotides (ODN) containing unmethylated CpG motifs are potent stimulators of the innate immune system, and are capable of aborting several infections in a non-specific manner. We here report studies of the capacity of such ODN to protect mice against infection with foot and mouth disease virus (FMDV). Susceptibility of Balb/c mice to infection with isolates from the different serotypes of FMDV was investigated, and, at the same time, the capacity of CpG ODN to modulate the infection was evaluated. Treatment with CpG significantly reduced viremia, disease and death in five of six serotypes, when compared to no treatment or treatment with a control ODN. The effect was observed when ODN was administered simultaneously with, or up to 12h after, infection with FMDV, and lasted for 14 days post treatment. The potential application of CpG ODN for control of FMDV during an outbreak is discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16678920     DOI: 10.1016/j.antiviral.2006.03.010

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  8 in total

1.  Sequence and phylogenetic analysis of the non-structural 3A and 3B protein-coding regions of foot-and-mouth disease virus subtype A Iran 05.

Authors:  Saber Jelokhani-Niaraki; Majid Esmaelizad; Morteza Daliri; Rasoul Vaez-Torshizi; Morteza Kamalzadeh; Mohsen Lotfi
Journal:  J Vet Sci       Date:  2010-09       Impact factor: 1.672

Review 2.  Antiinfective applications of toll-like receptor 9 agonists.

Authors:  Arthur M Krieg
Journal:  Proc Am Thorac Soc       Date:  2007-07

3.  Innate immune defenses induced by CpG do not promote vaccine-induced protection against foot-and-mouth disease virus in pigs.

Authors:  M P Alves; L Guzylack-Piriou; V Juillard; J-C Audonnet; T Doel; H Dawson; W T Golde; H Gerber; N Peduto; K C McCullough; A Summerfield
Journal:  Clin Vaccine Immunol       Date:  2009-06-24

Review 4.  Early inhibitors of human cytomegalovirus: state-of-art and therapeutic perspectives.

Authors:  Beatrice Mercorelli; David Lembo; Giorgio Palù; Arianna Loregian
Journal:  Pharmacol Ther       Date:  2011-04-28       Impact factor: 12.310

5.  Induction of a systemic antiviral state in vivo in the domestic cat with a class A CpG oligonucleotide.

Authors:  Céline Robert-Tissot; Marina L Meli; Barbara Riond; Regina Hofmann-Lehmann; Hans Lutz
Journal:  Vet Immunol Immunopathol       Date:  2012-08-04       Impact factor: 2.046

Review 6.  Laboratory animal models to study foot-and-mouth disease: a review with emphasis on natural and vaccine-induced immunity.

Authors:  Mohammed Habiela; Julian Seago; Eva Perez-Martin; Ryan Waters; Miriam Windsor; Francisco J Salguero; James Wood; Bryan Charleston; Nicholas Juleff
Journal:  J Gen Virol       Date:  2014-07-07       Impact factor: 3.891

7.  Stimulation with a class A CpG oligonucleotide enhances resistance to infection with feline viruses from five different families.

Authors:  Céline Robert-Tissot; Vera L Rüegger; Valentino Cattori; Marina L Meli; Barbara Riond; Peter F Moore; Monika Engels; Marco Franchini; Regina Hofmann-Lehmann; Hans Lutz
Journal:  Vet Res       Date:  2012-08-20       Impact factor: 3.683

8.  Synergistic effect of ribavirin and vaccine for protection during early infection stage of foot-and-mouth disease.

Authors:  Joo-Hyung Choi; Kwiwan Jeong; Su-Mi Kim; Mi-Kyeong Ko; Su-Hwa You; Young S Lyoo; Byounghan Kim; Jin-Mo Ku; Jong-Hyeon Park
Journal:  J Vet Sci       Date:  2018-11-30       Impact factor: 1.672

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.